glp 1 side effects libido Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it GLP-1 receptor agonists may dampen

A statistically significant increase in thyroid C-cell adenomas was observed in males and females at all dose levels, and a statistically significant increase in thyroid C-cell carcinomas was observed in males at 0.01 mg/kg/day, at clinically relevant exposures

Given ongoing concerns regarding suicidality, future trials should incorporate rigorous adverse event monitoring, especially for individuals concurrently using psychotropic medications, to ensure safe prescribing practices and inform regulatory oversight as GLP1RA use continues to expand

[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Pories W, Swanson M, MacDonald K, et al

Int J Obes (Lond) 2010

Frequently Asked Questions Is fatigue a common side effect of GLP-1 medications

In the future, semaglutide is likely to emerge as a more suitable treatment option for pasireotide-induced hyperglycemia